论文部分内容阅读
英国癌症研究中心的Jack Cuzick在《柳叶刀》杂志上发表文章指出,他莫昔芬的使用能否预防乳腺癌尚有待于进一步研究。 国际乳腺癌干预研究(IBIS-I)从英国、欧洲、澳大利亚及新西兰选取的7152位年龄在35～70岁之间的乳腺癌高危妇女。在该项为期5年
Jack Cuzick of the Cancer Research Center of the United Kingdom published an article in The Lancet and pointed out that the use of tamoxifen can prevent breast cancer remains to be further studied. International Breast Cancer Intervention Study (IBIS-I) 7152 women at high risk of breast cancer between the ages of 35 and 70 selected from the United Kingdom, Europe, Australia and New Zealand. During this period of 5 years